• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>MedImmune

MedImmune

  1. Global Influenza A Virus, H3N2 Subtype Infections Therapeutics Pipeline Review, H1 2017 - Research and Markets

    Global Influenza A Virus, H3N2 Subtype Infections Therapeutics Pipeline Review, H1 2017 - Research and Markets

12

©2017 Morningstar Advisor. All right reserved.